Oras Alabas retweeted
Do you have a heart condition and live with psoriasis? Your voice matters and we want to hear from you!
We are inviting people who live with both psoriasis and a heart condition (like high blood pressure, heart failure, or irregular heartbeat) to join a focus group to help shape a research study. This will help us to understand the link between skin and heart health and what matters to you.
If you are interested in being part of a Patient and Public Involvement focus group, please contact Dr Oras Alabas, a Research Fellow at BADBIR, via email: [email protected]
Oras Alabas retweeted
Do you have a heart condition and live with psoriasis? Your voice matters and we want to hear from you!
We are inviting people who live with both psoriasis and a heart condition (like high blood pressure, heart failure, or irregular heartbeat) to join a focus group to help shape a research study. This will help us to understand the link between skin and heart health and what matters to you.
If you are interested in being part of a Patient and Public Involvement focus group, please contact Dr Oras Alabas, a Research Fellow at BADBIR, via email: [email protected]
Oras Alabas retweeted
Multiple imputation with flexible parametric survival models thestatsgeek.com/2024/10/25/…
Oras Alabas retweeted
this being my single favorite video from the paris olympic games teapawt.net/bitizdravas/status/182…
Oras Alabas retweeted
**NEW pre-print**
"Sample size for developing a prediction model with a binary outcome: targeting precise individual risk estimates to improve clinical decisions and fairness"
+ new Stata module: pmstabilityss @joie_ensor
arxiv.org/abs/2407.09293
Feedback welcome 🙏
I’m delighted to present my work at the BAD. Using data of more than 15,000 patients we showed there is no increased risk of the development of keratinocyte carcinomas in psoriasis patients receiving biologic therapy compared to those on non-biologic systemic therapy.
I’m delighted to present my work on the “Risk of keratinocyte carcinomas in psoriasis patients treated with biologic therapy: analysis from BADBIR” as an oral presentation on Wednesday 3rd July at 11.15 Plenary session at the BAD annual meeting. So please join us!
Oras Alabas retweeted
I am honoured to share the stage with @ZZNYiu and @OrasAlabas and will cover the process of accessing data from one of the richest data sources on #psoriasis. So do come along and find out!
Looking forward to @HealthySkin4All #BAD2024 next week here in Manchester!
I will be speaking at the Hot Topics in Hall 2.1 on Tuesday 2nd July on how to ask a research question in @BADBIR along with @OrasAlabas and Shehnaz Ahmed
Oras Alabas retweeted
Here is our latest Eligibility criteria. We have recently opened recruitment to Spevigo (spesolimab) and small molecule Sotyktu (deucravacitinib)
Oras Alabas retweeted
Looking forward to @HealthySkin4All #BAD2024 next week here in Manchester!
I will be speaking at the Hot Topics in Hall 2.1 on Tuesday 2nd July on how to ask a research question in @BADBIR along with @OrasAlabas and Shehnaz Ahmed
Oras Alabas retweeted
Remember to check out key medical dermatology talks in Exchange Auditorium on Wednesday 3rd July
09:00 Duc Binh Phan - biosimilars in @BADBIR #psoriasis
09:35 Helen Alexander - treatment effectiveness #eczema from A-STAR register
11:15 @OrasAlabas - skin cancer risk @BADBIR
Oras Alabas retweeted
#Stata #sankey has been bumped to v1.73 with one major requested change:
- Ability to control drawing order of nodes through value labels. Flows can still be sorted through sort1() & sort2().
- Additional errors checks added.
More info on GitHub:
github.com/asjadnaqvi/stata-…
Oras Alabas retweeted
All models are wrong and yours are useless!
In case you missed my talk yesterday on how to make clinical prediction tools useful for patients, you can read all about it here.
Enjoy!
doi.org/10.1038/s41698-024-0…
Oras Alabas retweeted
Fixing some #Stata #reshape code, and a reminder that you can use irregular variable names to still reshape using the "@" symbol.
Oras Alabas retweeted
Time to ask the question- are your observational studies PRINCIPLED?
At Sentinel, we are setting the bar high for ourselves and hope the community will follow suit!
Check out @bmj_latest describing our process
A five step process guide to help ask and answer a causal question regarding drug treatment effects using healthcare data
@Rishidesai11 bmj.com/content/384/bmj-2023…






























